Nutra Pharma Corp. Reaches Settlement with SEC
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nutra Pharma Corp (NPHC)
Nutra Pharma Corp stock price live, this page displays OTC NPHC stock exchange data. View the NPHC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nutra Pharma Corp real time stock price chart below.
What Is the Nutra Pharma Corp Stock Price Today?
The Nutra Pharma Corp stock price today is 0.000001.
What Is the Stock Symbol for Nutra Pharma Corp?
The stock symbol for Nutra Pharma Corp is ""NPHC.""
What Stock Exchange Does Nutra Pharma Corp Trade On?
Nutra Pharma Corp is listed and trades on the OTC Markets stock exchange.
Is Nutra Pharma Corp a Good Stock to Buy?
Determining whether Nutra Pharma Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NPHC quote. (ISIN: US67060U2087)
What Is the Nutra Pharma Corp Stock Price Today?
The Nutra Pharma Corp stock price today is 0.000001.
What Is the Stock Symbol for Nutra Pharma Corp?
The stock symbol for Nutra Pharma Corp is ""NPHC.""
What Stock Exchange Does Nutra Pharma Corp Trade On?
Nutra Pharma Corp is listed and trades on the OTC Markets stock exchange.
Is Nutra Pharma Corp a Good Stock to Buy?
Determining whether Nutra Pharma Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NPHC quote. (ISIN: US67060U2087)
OTC Markets
Currency in USD
0.000001
-0.000099(-99.00%)
Closed·
Fair Value
An estimate of a Nutra Pharma Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.000001
0.000100
52 wk Range
0.000001
0.000300
NPHC Scorecard
Full Analysis
Stock has taken a big hit over the last week
Unusual trading volume
1/3
Fair Value
An estimate of a Nutra Pharma Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0000010.000100
52 wk Range
0.0000010.000300
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NPHC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Nutra Pharma Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Nutra Pharma Corp Company Profile
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps, and neuropathic pain, as well as a topical gel for treating joint pain, and pain associated with arthritis and repetitive stress; Pet Pain-Away, a homeopathic, non–narcotic, non–addictive, and over–the–counter pain reliever to treat chronic pain in companion animals; Luxury Feet, an over-the-counter pain reliever and anti–inflammatory product to treat pain or discomfort due to high heels and stilettos; Nyloxin Military Strength for treating pain to the United States Military and Veteran's Administration; and Equine Pain-Away, an over-the-counter topical pain reliever to relieve pain in horses. It is also involved in developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases comprising human immunodeficiency virus/AIDS and herpes, as well as for general anti-viral applications; RPI-78 for pain and arthritis; and RPI-70 for pain. The company was incorporated in 2000 and is based in Plantation, Florida.
Compare NPHC to Peers and Sector
Metrics to compare | NPHC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNPHCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −2.9x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 1.5x | 2.6x | |
Price / LTM Sales | 0.0x | 8.7x | 3.3x | |
Upside (Analyst Target) | 0.0% | 215.6% | 38.9% | |
Fair Value Upside | Unlock | −0.4% | 5.4% | Unlock |
Earnings
Latest Release
Nov 27, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Nutra Pharma Corp Trade On?
Nutra Pharma Corp is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Nutra Pharma Corp?
The stock symbol for Nutra Pharma Corp is "NPHC."
What Is the Nutra Pharma Corp Market Cap?
As of today, Nutra Pharma Corp market cap is 7.10K.
What Is Nutra Pharma Corp's Earnings Per Share (TTM)?
The Nutra Pharma Corp EPS (TTM) is 0.00.
From a Technical Analysis Perspective, Is NPHC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Nutra Pharma Corp Stock Split?
Nutra Pharma Corp has split 2 times.
How Many Employees Does Nutra Pharma Corp Have?
Nutra Pharma Corp has 4 employees.
What is the current trading status of Nutra Pharma Corp (NPHC)?
As of 30 Aug 2025, Nutra Pharma Corp (NPHC) is trading at a price of 0.000001, with a previous close of 0.00. The stock has fluctuated within a day range of 0.000001 to 0.000100, while its 52-week range spans from 0.000001 to 0.000300.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.